Expression of interest to develop an EQA for cfDNA multi-target testing

UPDATE: The deadline is passed (21 February). For further information, please contact executive@iqnpath.org IQN Path invites expressions of interest from all EQA provider members to collaborate to develop and deliver EQA to assess the standard of testing circulating free tumour DNA (cfDNA) for multiple biomarkers in plasma. The first IQN Path supported activity was a collaboration read more…